The 20 Best Agranulocytosis Doctors Near Me in Ann Arbor, MI

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Monalisa Ghosh, MD, Assistant Professor. Dr. Ghosh graduated with honors from the University of Alabama at Birmingham with a BS in Biomedical Engineering, minor in Mathematics and Chemistry. She earned her MD from the University of Alabama School of Medicine where she also completed her residency training. Her fellowship training was completed at the NIH/NCI Medical Oncology Fellowship Program. Dr. Ghosh’s research interest is in bone marrow trans-plantation and cellular therapies to treat lymphoma. Dr. Ghosh will be seeing patients on the BMT service. Dr. Ghosh is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Colonoscopy.

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Burke is board certified in Hematology and Medical Oncology.

Dr. Merz is from Spring Lake, MI. She earned a BA in Kinesiology and Spanish at Calvin College before obtaining her MD and Master's of Science in Clinical Research at the University of Michigan. She then completed internal medicine training at Brigham and Women's Hospital in Boston, MA before completing hematology/oncology fellowship at Dana-Farber Cancer Institute/Mass General Brigham.She joined the faculty at University of Michigan in 2025, specializing in women's health and classical hematology disorders like sickle cell disease, blood clots, ITP, or iron deficiency in pregnancy or with hormone therapy use.Dr. Merz's research work includes understanding the Duffy null phenotype-- a red blood cell variant common in people with African or Middle Eastern ancestry. She advocated to update the terminology around this variant to Duffy null-associated neutrophil counts (DANC), published the first Duffy null-specific absolute neutrophil count reference range, and was the principal investigator on a grant through the Doris Duke Foundation and the American Society of Hematology to accelerate the update of Duffy null reference ranges across the country. She now works to understand how to personalize diagnostics and treatment plans for people with the Duffy null variant-- especially in cancer care. She also does research in women's health and classical hematology including understanding how to prevent blood clots in pregnancy and optimizing iron stores throughout the reproductive lifespan.Outside of work, Dr. Merz is an active member in the Ann Arbor community and enjoys spending time with her husband and 2 greyhounds. Dr. Merz is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Agranulocytosis, Chronic Familial Neutropenia, Febrile Neutropenia, Thrombectomy, and Bone Marrow Transplant.

Dr. Ahmed is a medical hematologist/oncologist with a clinical focus on lymphoma, myeloma and coagulation disorders. She was raised in Toledo, Ohio, and completed her undergraduate training at the University of Akron. After receiving her medical degree from the Medical College of Ohio in Toledo, Dr. Ahmed completed a residency in internal medicine at Saint Joseph Mercy Hospital in Ann Arbor. She then completed fellowship training in hematology/oncology at U-M. Dr. Ahmed is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 54 other conditions, according to our data. Her clinical expertise encompasses Histiocytosis, Reticulohistiocytoma, Non-Langerhans-Cell Histiocytosis, Rosai-Dorfman Disease, and Bone Marrow Aspiration. Dr. Ahmed is board certified in Hematology.

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Mary Mcgrath is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Mcgrath is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Factor 11 Deficiency, Hemophilia A, Hemophilic Arthropathy, and Glanzmann Thrombasthenia. Dr. Mcgrath is board certified in Pediatric Hematology-Oncology and Pediatrics.

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

Attaphol Pawarode is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Pawarode is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Sarah Anand is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Anand is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy. Dr. Anand is board certified in Internal Medicine, Hematology, and Medical Oncology.

John Maciejewski is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Maciejewski is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

David Svilar is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Svilar is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. His clinical expertise encompasses Sickle Cell Disease, Hereditary Spherocytosis, Febrile Neutropenia, and Shwartzman Phenomenon. Dr. Svilar is board certified in Pediatric Hematology-Oncology and Pediatrics.

Dr. Magenau is currently an Assistant Professor at the University of Michigan and the Adult Clinical BMT director of the Blood and Marrow Transplantation Program. He holds a Bachelor of Science in Biology from Pennsylvania State University, and obtained his M.D. from the Temple University in Philadelphia, Pennsylvania. Dr. Magenau then trained in internal medicine at the University of Illinois in Chicago.Dr. Magenau is the lead clinical investigator on several trials including experience in clinical HCT, responsible research practices, team science, and conducting multicenter prospective HCT clinical trials in high risk populations (Acute Myeloid Leukemia not in remission at time of HCT). He also has a background in developing, performing, and monitoring HCT studies that integrate immune analysis of human samples. Dr. Magenau is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Magenau is board certified in Hematology.

Marcus Geer is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Geer is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Transplant. Dr. Geer is board certified in Internal Medicine, Medical Oncology, and Hematology.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy. Dr. Pettit is board certified in Medical Oncology and Hematology.

Mary Riwes is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Riwes is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Colonoscopy.